A dual antagonist of TP and EP4 receptors; inhibits TxA2-induced platelet aggregation (IC50 = 0.26 μM) and bronchial smooth muscle contraction; impairs PGE2-mediated relaxation of piglet saphenous vein, suppresses serum-induced proliferation of fibroblasts, and reduces metastasis in a mouse model of breast cancer.